Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 A-Mark Precious Metals, Inc. AMRK Dec 3, 2021 61.45 -2.91   
 A.O. Smith Corporation AOS Dec 3, 2021 81.60 +0.64   
 A10 Networks, Inc. ATEN Dec 3, 2021 15.12 -0.40   
 AAA - A Rated Corporate Bond Ishares QLTA Dec 3, 2021 56.75 +0.66   
 AAON, Inc. AAON Dec 3, 2021 79.52 +0.29   
 AAR Corp. AIR Dec 3, 2021 33.33 -0.66   
 Aarons Holdings Company, Inc. AAN Dec 3, 2021 22.81 -0.18   
 ABB Ltd ABB Dec 3, 2021 35.42 +0.34   
 Abbott Laboratories ABT Dec 3, 2021 130.27 +1.47   
 AbbVie Inc. ABBV Dec 3, 2021 118.85 +1.69   
 Abcam plc - American Depositary Shares ABCM Dec 3, 2021 22.06 -3.03   
 AbCellera Biologics Inc. - ABCL Dec 3, 2021 14.02 -5.46   
 Abeona Therapeutics Inc. ABEO Dec 3, 2021 0.57 -5.51   
 Abercrombie & Fitch Company ANF Dec 3, 2021 34.93 -1.08   
 Aberdeen Asia-Pacific Income Fund Inc FAX Dec 3, 2021 3.99 0.00   
 Aberdeen Australia Equity Fund Inc IAF Dec 3, 2021 5.86 -2.82   
 Aberdeen Emerging Markets Equity Income Fund, Inc. AEF Dec 3, 2021 7.92 -1.61   
 Aberdeen Global Dynamic Dividend Fund AGD Dec 3, 2021 11.77 -1.18   
 Aberdeen Global Income Fund, Inc. FCO Dec 3, 2021 8.07 -0.37   
 Aberdeen Global Premier Properties Fund AWP Dec 3, 2021 6.19 -0.80   
 Aberdeen Income Credit Strategies Fund ACP Dec 3, 2021 10.39 -2.72   
 Aberdeen Income Credit Strategies Fund 5.25% PRF PERPETUAL U ACP-A Dec 3, 2021 26.94 -0.02   
 Aberdeen Japan Equity Fund, Inc. JEQ Dec 3, 2021 8.78 +0.46   
 Aberdeen Standard Global Infrastructure Income Fund ASGI Dec 3, 2021 19.44 -0.51   
 Aberdeen Total Dynamic Dividend Fund AOD Dec 3, 2021 9.60 -1.03   
 ABG Acquisition Corp. I - Class A Ordinary Shares ABGI Dec 3, 2021 9.78 0.00   
 ABIOMED, Inc. ABMD Dec 3, 2021 300.63 -3.78   
 ABM Industries Incorporated ABM Dec 3, 2021 44.73 -1.28   
 Absolute Software Corp ABST Dec 3, 2021 8.49 -2.41   
 AC Immune SA ACIU Dec 3, 2021 4.85 -3.39   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK